The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
ResMed has entered into a definitive agreement to sell its MatrixCare software business to Frazier Healthcare Partners for $490 million. This strategic divestment is intended to sharpen the company's focus on its core sleep health business. MatrixCare contributed approximately $220 million in revenue and $55 million in non-GAAP operating profit for fiscal year 2026.